• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

13.17 -0.17 (-1.27%)
Delayed Quote Updated: 4:00 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,448,436
Open 13.26
Bid (Size) 13.00 (100)
Ask (Size) 13.22 (100)
Prev. Close 13.34
Today's Range 13.10 - 13.47
52wk Range 7.210 - 20.46
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ADMA Biologics (ADMA) Q3 2026 Earnings Call Transcript ↗
November 05, 2026
ASCENIV demand surged while BIVIGAM faced pressure, and receivables lagged the target range. 
Via The Motley Fool
Topics Earnings
Today's US Session: Top Stock Gainers and Losers ↗
November 05, 2026
Via Chartmill

Performance

52-Week Range 35.6% below 52-week high
13.17
7.2152W Low 20.4652W High
1 Week 7.3% below 1-week high
13.101W Low 14.201W High

ADMA Biologics Inc - Common Stock (ADMA) traded between $7.21 and $20.46 over the past 52 weeks and last traded at $13.17, 35.6% below its 52-week high. Over the past week it ranged between $13.10 and $14.20.

Past 12 Months
-2.2%
+19.6%
+33.8%
+59.8%
-26.3%
-19.5%
1W -$0.30
1M +$2.16
3M +$3.33
6M +$4.93
YTD -$4.71
1Y -$3.19

ADMA was -19.5% over the past year, +59.8% over six months, -26.3% year to date, -2.2% in the last week.

12 Months vs Market
ADMA
-19.5%
DIA
+5.0%
SPY
+4.1%
QQQ
+1.4%
IWM
+12.0%

Over the past 12 months ADMA returned -19.5% versus DIA (Dow) +5.0%, SPY (S&P 500) +4.1%, QQQ (Nasdaq 100) +1.4% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 0.76× 3-mo avg
Today 2,448,436 3-mo avg 3.2M
1W
3.0M
1M
4.0M
3M
3.2M
6M
3.1M
YTD
4.1M
1Y
4.0M

ADMA most recently traded 2,448,436 shares against a 3-month average daily volume of 3.2M.

More News

Read More
Notable Gap Movers on Nov. 5, 2026: AEHL and ZNB Gap Higher; VCYT and MNTN Gap Lower ↗
November 05, 2026
Via Chartmill
News headline image
ADMA Biologics Q3 Earnings Call Highlights ↗
November 04, 2026
Via MarketBeat
Topics Earnings
ADMA Biologics (NASDAQ:ADMA) Shares Slide as Q2 Results Miss Estimates ↗
August 05, 2026
Via Chartmill
After-Hours Market Movers: Nov. 4, 2026 Gainers and Losers ↗
November 04, 2026
Via Chartmill
News headline image
ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
November 04, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026
October 28, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
October 15, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law
August 10, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026
August 10, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA
August 09, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
August 07, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
ADMA BIOLOGICS CLASS ACTION DEADLINE AUGUST 10th: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th
August 07, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
August 07, 2026
Via Newsfile
Topics Lawsuit
News headline image
ADMA Biologics Deadline: Rosen Law Firm Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA
August 07, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
August 07, 2026
From SkyMedia, LLC
Via GlobeNewswire
News headline image
ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA
August 06, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law
August 06, 2026
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
ADMA Biologics Q2 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics Earnings
News headline image
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 05, 2026
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches
August 05, 2026
Via Newsfile
Topics Fraud
News headline image
DEADLINE NEXT WEEK: Berger Montague Advises ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Contact the Firm Before August 10, 2026
August 05, 2026
From Berger Montague
Via GlobeNewswire
News headline image
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
August 04, 2026
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA
August 04, 2026
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?
Yes, ADMA Biologics Inc - Common Stock is publicly traded.
What exchange does ADMA Biologics Inc - Common Stock trade on?
ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ADMA Biologics Inc - Common Stock?
The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
What is the current price of ADMA Biologics Inc - Common Stock?
The current price of ADMA Biologics Inc - Common Stock is 13.17
When was ADMA Biologics Inc - Common Stock last traded?
The last trade of ADMA Biologics Inc - Common Stock was at 11/20/26 04:00 PM ET
What is the market capitalization of ADMA Biologics Inc - Common Stock?
The market capitalization of ADMA Biologics Inc - Common Stock is 2.59B
How many shares of ADMA Biologics Inc - Common Stock are outstanding?
ADMA Biologics Inc - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap